Zenith Contract Services

Volvo Trucks Simplifies Truck Maintenance and Boosts Uptime with Volvo Blue Service Contract for Intelligent Maintenance

Retrieved on: 
Tuesday, May 2, 2023
ACT, Volvo, Maintenance, Convenience, Remote diagnostics, Mechanics, ISO 50001, Diagnosis, Volvo Trucks, 1988 Motorcraft Quality Parts 500, ISO, Platinum, Department of transportation, Zenith Contract Services, DOT, Risk, Safety, Software, Automotive industry, Citrus, Rail transport

Since first launching the Volvo Blue service contract, Volvo Trucks has onboarded and certified 37 dealer locations across the U.S., with an additional seven locations coming online in the near future.

Key Points: 
  • Since first launching the Volvo Blue service contract, Volvo Trucks has onboarded and certified 37 dealer locations across the U.S., with an additional seven locations coming online in the near future.
  • Adaptive Maintenance Approach to Increase Uptime — The Volvo Blue service contract provides an individualized maintenance plan for each vehicle based on its actual real-world usage.
  • Remote Diagnostics – By utilizing connected technology, Volvo Trucks can remotely diagnose whether a truck needs to be scheduled for maintenance or a repair.
  • “Customers who opt-in to the Volvo Blue service contract experience greater truck uptime than they’ve had before by reducing the number of oil changes and breakdowns with Volvo Trucks’ optimized service plan,” said Mike Furst, director, contract services & leasing technology solutions, Volvo Trucks North America.

Vizient Innovative Technology Contract Awarded to Fresenius Kabi for the Ivenix Infusion System

Retrieved on: 
Monday, April 17, 2023
Medical Devices, Health, Hospitals, Health Technology, General Health, Biotechnology, Information, Fresenius (company), AUC, Global Health Innovative Technology Fund, Zenith Contract Services, Hospital, Patient, Patient safety, Nursing, Medical device, Vizient, Inc.

Fresenius Kabi announced today its Ivenix Infusion System has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company.

Key Points: 
  • Fresenius Kabi announced today its Ivenix Infusion System has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company.
  • Innovative Technology contracts are recommended after review and interaction with products submitted through Vizient's Innovative Technology Program.
  • The contract sets terms for hospitals to evaluate and purchase the Ivenix Infusion System, an advanced and user-friendly infusion pump system.
  • “We are thrilled to be awarded an Innovative Technology contract from Vizient for the Ivenix Infusion System,” said Christian Hauer, Executive Board Member and President of Fresenius Kabi MedTech.

Vizient Innovative Technology Contract Awarded to Fresenius Kabi for the Ivenix Infusion System

Retrieved on: 
Monday, April 17, 2023
Biotechnology, Practice Management, Pharmaceutical, Medical Supplies, Health, Medical Devices, Hospitals, Health Technology, Information, Fresenius (company), AUC, The Queen's Award for Enterprise: Innovation (Technology) (2011), Multimedia, Zenith Contract Services, Hospital, Patient, Patient safety, Nursing, Medical device, Vizient, Inc.

Fresenius Kabi announced today its Ivenix Infusion System has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company.

Key Points: 
  • Fresenius Kabi announced today its Ivenix Infusion System has received an Innovative Technology contract from Vizient, Inc. the nation's largest member-driven health care performance improvement company.
  • The contract sets terms for hospitals to evaluate and purchase the Ivenix Infusion System, an advanced and user-friendly infusion pump system.
  • “We are thrilled to be awarded an Innovative Technology contract from Vizient for the Ivenix Infusion System,” said Christian Hauer, Executive Board Member and President of Fresenius Kabi MedTech.
  • Vizient may award a contract to products deemed worthy of the Innovative Technology designation outside of the competitive bid cycle.

Aseptic Fill Finish Global Market Report 2023: Growing Demand for Aseptic Fill Finish Services Bolsters Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 11, 2023
Chemicals, Plastics, Manufacturing, Molecule, Vaccine, APL, Charles River Laboratories, Hetero Drugs, Partnership, Fresenius (company), Patheon, Powder, Lonrho, Overalls, Research, Antibody, Type, Organization, Zenith Contract Services, Protein, Risk, Peptide, Approved Drug Products with Therapeutic Equivalence Evaluations, WuXi Biologics, Health, Robotics, Intas Pharmaceuticals, Oligonucleotide, Safety, Syringe, Fine chemical, Marketing, Glass, Airline, Oil

The report features an extensive study of the current market landscape and future opportunity for the aseptic fill finish service providers.

Key Points: 
  • The report features an extensive study of the current market landscape and future opportunity for the aseptic fill finish service providers.
  • In fact, a number of companies are involved in offering biologics fill finish services and small molecule fill finish services.
  • Answer: The global aseptic fill finish services market is expected to grow at a CAGR of 7%, during the period 2023-2035.
  • Answer: Presently, the vials (67%) account for the largest share in the global aseptic fill finish services market.

CraniUS Announces a Strategic Partnership with Leading Drug and Device Manufacturer, Medical Product Laboratories

Retrieved on: 
Tuesday, April 11, 2023
Glioblastoma, Myenteric plexus, Partnership, GBM, ISO, EVP, Medicine, Zenith Contract Services, MPL, Patient, CED, Celebrity board director, FDA, Medical device, Pharmaceutical industry

BALTIMORE, April 11, 2023 /PRNewswire/ -- CraniUS LLC, an R&D company focused on building breakthrough diagnostics and treatments for neurosurgical patients with chronic brain disease announced a critical partnership with leading FDA-registered drug and device manufacturer, Medical Product Laboratories, Inc (Phila.

Key Points: 
  • BALTIMORE, April 11, 2023 /PRNewswire/ -- CraniUS LLC, an R&D company focused on building breakthrough diagnostics and treatments for neurosurgical patients with chronic brain disease announced a critical partnership with leading FDA-registered drug and device manufacturer, Medical Product Laboratories, Inc (Phila.
  • Medical Products Laboratories, Inc, a full-service drug and device contract manufacturer, has nearly 100 years' experience in the industry and is led by serial entrepreneur, Mr. Elliot Stone (President/CEO).
  • "CraniUS is honored to have a world-class partner on the drug manufacturing side in Medical Product Laboratories," said Michael Maglin, CEO of CraniUS.
  • Without question, this partnership opens numerous opportunities for us to enable multiple brain disease treatments including GBM (Glioblastoma multiforme)."

Superior Drilling Products, Inc. Delivers Revenue Growth of 43% to $19.1 million with Expanded Margins and Earnings per Share of $0.04 in 2022

Retrieved on: 
Friday, March 10, 2023
Mining, Minerals, Oil, Gas, Manufacturing, Energy, Natural Resources, Other Manufacturing, Webcast, Growth, Composition, International, DNR, Zenith Contract Services, Public expenditure, Video game

Revenue in North America was up 46%, while International growth was 27%.

Key Points: 
  • Revenue in North America was up 46%, while International growth was 27%.
  • Full year 2022 capital expenditures of $3.3 million were related to machining capacity expansion, higher maintenance activities, and an increase in the Company’s Middle East DNR rental tool fleet.
  • The Company expects its capital spending for fiscal 2023 to range between $3.0 million to $3.5 million.
  • Contract Services revenue is comprised of repair and manufacturing services for drill bits and other tools or products for customers.

Superior Drilling Products, Inc. Announces Preliminary Full Year 2022 Revenue Growth of Approximately 44%; 2023 Initial Revenue Guidance Suggests Further Growth

Retrieved on: 
Tuesday, February 14, 2023
Mining, Minerals, Oil, Gas, Manufacturing, Energy, Natural Resources, Other Manufacturing, DNR, Investment, Zenith Contract Services, Webcast, SDPI, NYSE, SDP, Sale, Letter, International, Marketing, Growth, Video game

The midpoint of the preliminary range represents an increase in revenue of 44% over 2021.

Key Points: 
  • The midpoint of the preliminary range represents an increase in revenue of 44% over 2021.
  • Fourth quarter 2022 preliminary revenue is expected to be in the range of $5.2 million to $5.3 million and comprised of 85% from North America with the remaining from International markets.
  • Preliminary results are subject to change pending review by the Company’s independent accountants.
  • As part of the agreement, SDP anticipated receiving an initial $3.8 million purchase of DNR tools during the fourth quarter of 2022.

Vizient Announces 2023 Innovative Technology Exchange, Supplier Applications Now Being Accepted

Retrieved on: 
Tuesday, January 31, 2023
Medical Supplies, Medical Devices, Health, Hospitals, Practice Management, Pharmaceutical, Zenith Contract Services, Safety, Hospital, Massachusetts Innovation & Technology Exchange, Vizient, Inc.

Vizient, Inc. announced today it is accepting applications for its 2023 Innovative Technology Exchange and encouraged suppliers of medical equipment and technology who want to showcase their products to healthcare decision makers from across the country to participate.

Key Points: 
  • Vizient, Inc. announced today it is accepting applications for its 2023 Innovative Technology Exchange and encouraged suppliers of medical equipment and technology who want to showcase their products to healthcare decision makers from across the country to participate.
  • The event is part of a process that can earn candidates a Vizient Innovative Technology contract or designation for their product.
  • “It’s a great opportunity to share information about products that can potentially make a difference in healthcare.”
    The annual Innovative Technology Exchange is part of Vizient’s Innovative Technology Program that includes product review of supplier-submitted technologies by member-led councils and task forces.
  • Since 2003, Vizient has reviewed over 3,000 technologies as part of its Innovative Technology Program.

Mikart invests in new liquids and suspensions suite to enhance liquid oral drug product development and manufacturing capabilities of complex formulations

Retrieved on: 
Tuesday, January 31, 2023
The central science, Investment, CDMO, Zenith Contract Services, Temperature, GMP, Doctor of Philosophy, Agility, Fine chemical

ATLANTA, Jan. 31, 2023 /PRNewswire/ -- Mikart, LLC –a comprehensive contract development and manufacturing organization announced the completion of a new liquids and suspensions suite in Atlanta, Georgia.

Key Points: 
  • ATLANTA, Jan. 31, 2023 /PRNewswire/ -- Mikart, LLC –a comprehensive contract development and manufacturing organization announced the completion of a new liquids and suspensions suite in Atlanta, Georgia.
  • The investment is in response to clients' demand to provide expert contract services to develop robust, reliable liquid dosage forms.
  • This investment further supports our growing geriatric and pediatric product development and manufacturing capabilities .
  • "We continue to see strong demand for liquid and suspension products across several indications," commented Nazar Elkarim, PhD Vice President of Product Development Services at Mikart.

Wabash Announces Long-Term Agreement with J.B. Hunt

Retrieved on: 
Tuesday, January 10, 2023
Transport, Ecosystem, Student Transportation Inc., J. B. Hunt, Hydro, Zenith Contract Services, NYSE, WNC, Airline, Rail freight transport

LAFAYETTE, Ind., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Wabash (NYSE: WNC) , the visionary leader of connected solutions for the transportation, logistics and distribution industries, today announced a multi-year supply agreement with J.B. Hunt Transport Inc., one of the largest supply chain solutions providers in North America.

Key Points: 
  • LAFAYETTE, Ind., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Wabash (NYSE: WNC) , the visionary leader of connected solutions for the transportation, logistics and distribution industries, today announced a multi-year supply agreement with J.B. Hunt Transport Inc., one of the largest supply chain solutions providers in North America.
  • This marks a strategic shift in how Wabash is intentionally building a backlog with strategic customers who are interested in jointly planning demand for a period that looks beyond the next 12 months.
  • It's essential to our mission of creating the most efficient transportation network in North America.”
    This long-term order agreement with J.B. Hunt couples with Wabash’s 10-year aluminum supply agreement with Hydro , strategically coordinated to provide certainty that Wabash can meet pent-up demand as its additional dry van capacity comes online in early 2023.
  • Wabash (NYSE: WNC) is the visionary leader of connected solutions for the transportation, logistics and distribution industries that is Changing How the World Reaches You®.